Our evaluation of immunohistochemical galectin-4 expression clearly showed that galectin-4 expression is associated with clinicopathologic variables of disease progression such as tumor size, pleural or venous invasion, nodal status, and TNM stage. The gene discussed is LGALS4; the disease is neoplasm.